Navigation Links
Bionovo Announces Third Quarter 2009 Highlights and Financial Results
Date:11/5/2009

nufacturing and analytical strategy for guaranteeing the consistency of its drug products. The Company is currently concluding work on the analytical method application and the commercial scale manufacturing batches.
  • Bionovo presented the positive results of its Phase 2 clinical trial of Menerba to the international women's health community at the 8th Annual European Society for Gynecology (EGS) in Rome, Italy. The overall reaction of the European scientific, clinical, and pharmaceutical community was extremely positive and demonstrated an international interest in finding a safer alternative to hormone therapy for the treatment of menopausal vasomotor symptoms.
  • The Company presented the results of a study on the effects of two plant-derived, tissue-selective estrogen receptor alpha (ERa) modulators (TSERaM) on menopausal obesity at the 20th Annual Meeting of the North American Menopause Society. In this study, plant-derived TSERaMs, like estrogens, were shown to reduce body fat in mice, but while estrogens also caused cell proliferation in the mammary gland and uterus, the plant-derived TSERaMs did not elicit these potentially cancer-causing side effects. These results suggest that the development of botanically-derived, tissue-selective ERa modulators could result in a safer alternative for the treatment of menopausal weight gain, a condition that can lead to the development of metabolic syndrome, a combination of risk factors for cardiovascular disease and diabetes.
  • Bionovo published a paper describing the molecular mechanisms underlying the selective cytotoxic activity of its preclinical drug candidate BN108 and its active compound, timosaponin AIII (TAIII), in the peer-reviewed, open-access journal, Public Library of Science One. BN108 and TAIII kill tumor cells by eliciting two responses: first, they inhibit mTORC1, an oncogenic pathway that is abnormally activated in many tumors, and second, they induce a profound stress in the en
    '/>"/>

    • SOURCE Bionovo, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2009 Financial Results on Thursday, November 5, 2009
    2. Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
    3. Bionovo Announces Second Quarter 2009 Highlights and Financial Results
    4. Bionovos Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity
    5. Bionovo Announces First Quarter 2009 Highlights and Financial Results
    6. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
    7. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
    8. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
    9. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
    10. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
    11. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/25/2009)...AMINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire-FirstCal...HIN),aleadinginnovatorandprovideroflessinvasive,mi...izingthetreatmentofadvancedheartfailure,todayannou...tthe21stAnnualPiperJaffrayHealthCareConferenceat8:...eingheldattheNewYorkPalaceHotel,December1-2. ,,...
    (Date:11/24/2009)...DISON,N.J.,Nov.24/PRNewswire-FirstCall/--QuestDiag...roviderofdiagnostictesting,informationandservices,...perJaffrayHealthcareConferenceinNewYorkCity.Thepre...:30a.m.EasternTime. ,, Duringtheconference,thec...oapproximate3%,operatingincometoexceed18%ofrevenue...
    (Date:11/24/2009)...EASANTON,Calif.,Nov.24/PRNewswire-FirstCall/--Thor...e-basedmechanicalcirculatorysupporttherapiestosave...lbeparticipatinginthe21stAnnualPiperJaffrayHealthC...th,executivevicepresidentandchieffinancialofficer,....,EasternStandardTime(5:30a.m.,PacificStandardTime...
    Breaking Medicine Technology:Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Two Years Remain for Physicians to Obtain Sleep Medicine Certification without Fellowship Training 52419 1Two Years Remain for Physicians to Obtain Sleep Medicine Certification without Fellowship Training 52419 2Two Years Remain for Physicians to Obtain Sleep Medicine Certification without Fellowship Training 52419 3Two Years Remain for Physicians to Obtain Sleep Medicine Certification without Fellowship Training 52419 4Access Pharmaceuticals to Present at Jesup 26 Lamont 2009 Growth Stock Conference 52416 1Access Pharmaceuticals to Present at Jesup 26 Lamont 2009 Growth Stock Conference 52416 2Aflac Incorporated To Release Second Quarter Results on July 29 2009 52413 1Aflac Incorporated To Release Second Quarter Results on July 29 2009 52413 2
    (Date:11/25/2009)...ingTogethertoShareRecordsSafely,ImproveCare ,...artmentofVeteransAffairs(VA)andKaiserPermanentetod...ndservicestoourNation,sheroes.VAandKaiserPermanent...threcord(EHR)informationusingtheNationwideHealthIn...thandHumanServices. ,, "Theabilitytosharecritic...
    (Date:11/25/2009)...KECITY,Nov.25/PRNewswire/--dazzlesmile,llc www.daz...alhealthscience.com havefileda67-pagefederallawsui...,Inc.,JesseWillms,FarendServicesLimited,andAtLastF...StatesDistrictCourtfortheDistrictofUtah,allegesmas...ile(TM)brandedteethwhiteningproducts,violationsoft...
    (Date:11/25/2009)...RA,Fla.,Nov.25/PRNewswire/--DanielTouizer,CEOof C...teedissuehealthinsurancebenefitprograms,isconcerne...meansnearlyoneinfiveAmericansarewithoutafull-timej...mploymentratesaredeterminedbytheU-6number,whichhas...ani e l T ouizer ."Thesestatisticsarealarming...
    (Date:11/25/2009)...Two signaling pathways essential to normal human d...growth factor receptor (EGFR) pathways - interact ...etastasis, researchers from The University of Texa...25 issue of Molecular Cell . , This newly chara...onents known to correlate with invasive cancer - a...
    (Date:11/25/2009)... - The American Society of,Hematology (ASH) is pl...rs with,the highest scoring abstracts in the cate... graduate student, resident physician, and post-do... honorarium plus annual meeting,travel reimbursem... Undergraduate,Student , Kimberly Fan , Donor...
    Breaking Medicine News(10 mins):Health News:VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program 2Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Cinergy Health Commentary on Health Care for the Unemployed 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:ASH announces 2009 Merit Award winners 2
    ...ganization, CINCINNATI, May 27 Berkeley Premium ...fficulties and seeing positive results.,Consumers ... and at retail., Despite the recent economic down...ct launches and more aggressive,recruiting., Thro...
    ... infrastructure for MRF,s collaborative ...f., May 27 Collaborative Drug,Discovery, Inc. (CD...ich,organizes preclinical research data to help sc...aborate more,effectively., MRF,s Accelerated Rese...
    ...(TM), An Organic First For Children,s ... May 27 While whole food,chemical-free nutrition ...nt, parents have had a singular choice with childr...od complexed vitamins and supplements -- gives par...
    ...py with simple series of head, body movements to c...News) -- The best treatment for vertigo is the eas... Academy of Neurology guideline. , The guideline...series of head and body movements performed by a d...
    ... Corporation,(Nasdaq: SMTS ) announced today that...od and Drug Administration (FDA) to expand the lab...em., "We believe this new 510(k) will serve to su...t, the 510(k) expands,the indication for use to in...
    ... the nation,s,largest pharmacy benefits management...nnsylvania and 28 other states resolving claims of...Tom Corbett said the agreement was reached with,Ex...s is required to change its,business practices and...
    Other Medicine News:Health News:Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership 2Health News:Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership 3Health News:Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership 4Health News:Finally ... A Pure and Perfect Multi-Vitamin for Every Kid 2Health News:Finally ... A Pure and Perfect Multi-Vitamin for Every Kid 3Health News:Best Treatment for Vertigo Is Easiest One 2Health News:Somanetics Receives 510(k) Clearance From the FDA to Expand INVOS System Labeling 2Health News:Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Express Scripts Inc. 2Health News:Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Express Scripts Inc. 3
    ...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
    ...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
    ...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
    ...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
    Medicine Products: